Answers are grounded in this paper and cite their sources.
Demonstrates KLF6's role in neuronal injury, indicating therapeutic targets for stroke.
Stroke is an acute cerebrovascular condition marked by high rates of disability and mortality. Kruppel-like factor 6 (KLF6), a pivotal transcription factor, is integral to cell proliferation and differentiation. This study aims to elucidate the role of KLF6 in neuronal injury triggered by OGD/R and to uncover its underlying mechanisms. Cell viability, pyroptosis and ferroptosis were determined. Gene expression analysis was conducted via Western blot. m6A modification sites on KLF6 mRNA were predicted using the SRAMP website, and the m6A modification level was quantified through the MeRIP assay. Furthermore, the interaction between KLF6 and methyltransferase-like 14 (METTL14) was validated using the dual luciferase reporter assay. OGD/R treatment induced pyroptosis and ferroptosis in PC12 cells. Knockdown of KLF6 in PC12 cells effectively inhibited pyroptosis and ferroptosis that were induced by OGD/R. METTL14 stabilized KLF6 expression via m6A methylation modification. Knockdown of METTL14 attenuated OGD/R-induced pyroptosis and ferroptosis in PC12 cells, yet this inhibitory effect was counteracted by KLF6 overexpression. Additionally, METTL14 inhibited the activity of the AMPK/mTOR pathway by targeting KLF6. Our findings unveil the METTL14/KLF6 axis as a novel regulator of neuronal death post-ischemia, offering new insights and potential therapeutic targets for stroke.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: